Voyager Therapeutics (VYGR) Stock Price
$4.22 0%
to add to portfolio
AI Score
-
Alternative
1 -
Fundamental
4 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Voyager Therapeutics, AI stock picks, stock alerts and much more.
VYGR AI Stock Analysis
AI stock analysis for VYGR is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Voyager Therapeutics (VYGR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Voyager Therapeutics (VYGR) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Voyager Therapeutics (VYGR), currently trading at $4.22, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VYGR
-
Voyager Therapeutics, Inc.
-
Symbol
VYGR
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
230.5M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
VYGR Alternative Data
Web Traffic
Voyager Therapeutics receives an estimated 5875 monthly visitors to voyagertherapeutics.com.
-
Web Traffic
5875
-
Change from Previous Month
46.2%
-
3 Month Change
6.1%
-
YoY Change
6.1%
News Mentions
Voyager Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
Voyager Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Voyager Therapeutics has 918 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.
-
Twitter Followers
918
-
Daily Change
0.1%
-
1 Month Change
0.4%
-
3 Month Change
4.1%
LinkedIn Followers
39,166 are following Voyager Therapeutics on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
39166
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
1.8%
Job Postings
Voyager Therapeutics currenly has an estimated 10 open job postings, up by 11.1% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
11.1%
-
3 Month Change
42.9%
LinkedIn Employees
According to LinkedIn, Voyager Therapeutics has 195 employees, down by -3.5% over the last month.
-
LinkedIn Employees
195
-
Daily Change
0%
-
1 Month Change
3.5%
-
3 Month Change
3.5%
Business Outlook
-
Business Outlook
54
-
Change from Previous Month
19.4%
-
3 Month Change
0%
-
YoY Change
0%
VYGR Financials
VYGR Key Metrics
-
Total Revenue
$24.6M
-
Net Income
-$9M
-
Earnings per Share
-$0.16
-
Free cash flow
-$28.2M
-
EBITDA
-$12.6M
-
EBITDA Ratio
-0.513541
-
Total Assets
$426M
VYGR 2-year Revenue & Income
VYGR 2-year Free Cash Flow
VYGR Technicals
VYGR SMA
VYGR RSI
FAQ
What's the current price of Voyager Therapeutics (VYGR) Stock?
The price of an Voyager Therapeutics (VYGR) share is $4.22.
What's the market cap of Voyager Therapeutics?
The current market cap of Voyager Therapeutics is 230.5M.
Should I buy or sell VYGR?
Voyager Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Voyager Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Voyager Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Voyager Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Voyager Therapeutics (VYGR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Voyager Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Voyager Therapeutics (VYGR) that investors often compare it to?
Voyager Therapeutics (VYGR) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Voyager Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Voyager Therapeutics' stock price to be around $3.76 in 2026. Starting from the current price of $4.22, this represents a 10.9% change in price, indicating a bearish outlook for the stock.
How to buy Voyager Therapeutics (VYGR) Stock?
Voyager Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Voyager Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.